Conversation Guide: Talking to Your Doctor About Emerging Myelofibrosis Treatment Options
Download Guide Download Guide See More from EVOLVE Myelofibrosis
Interested in a Myelofibrosis Clinical Trial? Start Here.
https://vimeo.com/1153993163 Considering participating in a myelofibrosis clinical trial but not sure where to start? Dr. Gabriela Hobbs shares advice to help patients and care partners learn about clinical trials—from understanding…
Bone Marrow Transplant for Myelofibrosis | What You Should Know
https://vimeo.com/1153993197 Is bone marrow transplant something you should be asking your healthcare team about now? Dr. Gabriela Hobbs discusses outdated fears around transplant for myelofibrosis, how outcomes have improved significantly,…
Looking Forward | The Evolving Myelofibrosis Treatment Landscape
https://vimeo.com/1153993211 Dr. Gabriela Hobbs provides insight into the future of myelofibrosis care, explaining how research is moving beyond symptom relief toward therapies that target the underlying biology of the condition….
ASH 2025 Update | Myelofibrosis Treatment and Research Findings
https://vimeo.com/1153993264 Dr. Gabriela Hobbs discusses important new developments in myelofibrosis treatment from the American Society of Hematology annual meeting. Dr. Hobbs highlights emerging therapies, novel combination approaches, and encouraging trial…
Self-Advocacy | Why In-Depth Cancer Testing Is Essential
https://vimeo.com/1143931847 Dr. Heidi Gray explains why speaking up and asking about in-depth cancer testing can make a real difference in understanding your cancer care. With today’s rapidly evolving testing options…
Molecular Testing and Hereditary Testing: What’s the Difference?
https://vimeo.com/1143931665 What is the difference between hereditary (genetic) testing and molecular testing in cancer care? Dr. Heidi Gray defines the tests in simple terms and shares how test results can…
When Should Someone With Cancer Undergo Molecular Testing?
https://vimeo.com/1133948722 Cancer researcher Dr. Paul Oberstein explains when patients should undergo molecular testing and why early testing can be crucial. Dr. Oberstein also discusses new methods like blood-based assays that…
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
https://vimeo.com/1133948743 Dr. Paul Oberstein explains how molecular testing has revolutionized cancer care, providing doctors with an essential tool to personalize treatment and, in many cases, improve outcomes for people with…
Myelofibrosis Clinical Trials | The Benefits of Patient Participation
https://vimeo.com/1036132472 How do clinical trials fit into a myelofibrosis treatment plan? Dr. Idoroenyi Amanam discusses the benefits of clinical trial participation and advice for patients who may be hesitant to…
Why Myelofibrosis Patients Should Be Engaged in Their Care Decisions
https://vimeo.com/1036132463 Dr. Idoroenyi Amanam, a myeloproliferative disorder specialist and researcher from City of Hope, shares expert perspective on the importance of patient participation in care and treatment decisions. Dr. Amanam emphasizes…
Promising Advances in Myelofibrosis Research | Optimism for Patients
https://vimeo.com/1036132446 Dr. Idoroenyi Amanam from City of Hope discusses how the availability of newer JAK inhibitor therapies is providing better options for myelofibrosis patients. Dr. Amanam also shares how researchers…